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Abstract – Neo-tanshinlactone (1) was synthesized by the intramolecular 
coupling reaction of the precursor ester, which was prepared from the 
corresponding furan carboxylic acid (13) and naphthol (3), using a palladium 
reagent. 
Neo-tanshinlactone (1) is a natural heterocyclic compound, which was isolated 
from the rhizome of Salvia miltiorrhiza Bunge, and its chemical structure was 
elucidated in 2004 by Lee and co-workers who also achieved the first synthesis 
of 1.1 As its biological activity, compound 1 exhibited a potent inhibition 
against several cancer cell lines.2 Due to such a significant biological activity, 
the total synthesis of this compound is still an interesting theme in the field of 
both organic synthesis and medicinal chemistry. 
Recently, we have intensively studied the palladium-mediated aryl-aryl coupling reaction in an 
intramolecular manner to conveniently prepare polycyclic aromatic compounds.3 This method has been 
utilized for the synthesis of 6H-dibenzo[b,d]pyran-6-one type natural products,4 such as graphislactones, 
alternariol, arnottin I, etc.5 It was expected that this intramolecular aryl-aryl coupling could also be used 
as a key step for the total synthesis of neo-tanshinlactone 1.  
Our synthetic plan was straightforward as illustrated in Scheme 1 in which 1 would be synthesized by the 
intramolecular aryl-aryl coupling reaction of the precursor ester 2. Compound 2 would be prepared by the 
simple esterification between the corresponding naphthol 3 and furan 4. The two fragments 3 and 4 would 
easily be derived from 5-methoxytetralone 5 and itaconate ester 6, respectively.  
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   Scheme 1. Synthetic plan for neo-tanshinlactone (1) 
 
We initially prepared the naphthol 3 from 5 by Lee’s method.1 On the other hand, for the synthesis of the 
2,3,4-trisubstituted furan compound 4, dimethyl itaconate 6 was selected as the starting material.  
According to the reported method,6 6 was successively treated with bromine and triethylamine to form the 
allylic bromide 7, which was converted to the formate 8 by substitution with formic acid (Scheme 2).7 
The treatment of the formate 8 under acidic conditions afforded the five-membered lactone 9 in moderate 
yield.  
Introduction of the methyl group on the furan ring was performed via a series of a [3+2] cycloaddition of 
diazomethane and a denitrogenation process.8 The cycloaddition between 9 and diazomethane 
successfully afforded the pyrazole 10, which was transformed into the methyl product 11 under a heated 
condition. Aromatization of the furanone 11 was carried out by the two-step sequence of the DIBAL 
reduction and the acid treatment with TsOH. Hydrolysis of the methyl ester generated the furan 
carboxylic acid 12 which was iodinated at the 2-position using LDA and I2 to produce the iodofuran 13.9 
 
 
 
 
 
 
 
 
  Scheme 2. Preparation of 2-iodo-4-methyl-3-furancarboxylic acid (13) 
 
After the conventional ester formation, the key ester 14 was obtained (Scheme 3). In the final step, the 
various reaction conditions were examined in detail for the intramolecular coupling. As a result, the 
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 combination of Pd(OAc)2 (10 mol %), nBu3P (20 mol %), Ag2CO3, (200 mol %), and DMA provided the 
best yield (57%).  
 
 
 
 
 
  Scheme 3. Synthesis of neo-tanshinlactone (1) 
 
Thus, the total synthesis of 1 was completed. The spectral data of the synthesized 1 matched those of the 
authentic sample. 
In summary, the palladium-mediated aryl-aryl coupling reaction was effective for the total synthesis of 
neo-tanshinlactone (1). This technique will be useful for the construction of other polycyclic compounds 
containing a furan ring. 
EXPERIMENTAL 
General: Melting points were measured using a Yanaco micromelting point hot-plate apparatus 
(MP-500D) and are uncorrected. The IR spectra were recorded using a SHIMADZU FT-IR-8400 
spectrophotometer. The NMR spectra were obtained using a JEOL α-400 instrument. The elemental 
analysis was performed by a Vario MICRO-cube or Perkin-Elmer 2400II analyzer. The silica gel column 
chromatography was carried out using a Wakogel C-200. All reactions were carried out under N2 
atmosphere. 
5-Methylnaphthol (3),1 dimethyl 2-bromomethylfumarate (7),6 dimethyl 
2-formyloxymethylfumarate (8),7 3-methoxycarbonyl-2,5-dihydrofuran-5-one (9),7 
6a-methoxycaronyl-3a,4,6,6a-tetrahydrofuro[3,4-c]pyrazole-4(1H)-one (10),8 
4-methyl-3-methoxycarbonyl-2,5-dihydrofuran-5-one (11),8 and 4-methyl-3-furancarboxylic acid 
(12)8,9 were prepared by the reported methods. 
2-Iodo-4-methyl-3-furancarboxylic acid (13) 
n-Butyllithium (16.4 mmol (hexane solution)) was dropwise added to a solution of diisopropylamine 
(2.30 mL, 16.4 mmol) in dry THF (20.0 mL) at -78 oC, then the mixture was stirred for 15 min. To the 
LDA solution, a solution of 12 (1.00 g, 7.14 mmol) in THF (20 mL) was dropwise added at -78 oC. The 
reaction mixture was warmed to rt and allowed to stand for 20 min. A solution of freshly sublimed I2 
(2.00 g, 7.88 mmol) in THF (40 mL) was added dropwise to the reaction mixture at -78 oC, and then the 
mixture was warmed to rt. After 30 min, the reaction was quenched with water, then the mixture was 
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 acidified with a 10% HCl aqueous solution. After extractive work-up with ether, the organic layer was 
washed with a sat. Na2S2O3 aqueous solution and brine, then dried over MgSO4. Evaporation of the 
solvent gave a residue which was subjected silica gel column chromatography (hexane:ether = 2:1), and 
then the obtained material was recrystallized from ether-hexane to afford colorless needles of 13 (1.07 g, 
59%), mp 150.8 - 151.3 ºC (Et2O-hexane). 1H-NMR (400 MHz, (CD3)2CO) δ : 2.18 (3H, d, J = 1.2 Hz, 
CH3), 7.65 (1H, q, J = 1.2 Hz, 5-H). 13C-NMR (100 MHz, (CD3)2CO) δ : 10.1, 101.1, 123.8, 124.8, 147.0, 
163.9.  IR (KBr) cm-1 : 769.5, 941.2, 1111, 1252, 1302, 1516, 1684, 2974. Anal. calcd for C6H5IO3 : C, 
28.60 ; H, 2.00. Found : C, 28.87 ; H, 2.23. 
2-Iodo-4-methyl-furan-3-carboxylic acid 5-methyl-naphthalen-1-yl ester (14) 
A mixture of 3 (616 mg, 3.90 mmol), 13 (991 mg, 3.93 mmol), EDC (1.22 g, 6.36 mmol), DMAP (97.5 
mg, 0.798 mmol), and CH2Cl2 (30 mL) was stirred for 1.5 h at rt. The mixture was diluted with CH2Cl2 
and then washed with water and brine. After drying over MgSO4, the solvent was evaporated to give a 
residue which was subjected to silica gel column chromatography (hexane:Et2O = 5:1). Recrystallization 
from ether afforded the colorless solid of 14 (1.12 g, 73%), mp 121.5 - 121.9ºC (Et2O). 1H-NMR (400 
MHz, (CD3)2CO) δ : 2.32 (3H, d, J = 1.2 Hz, 4-Me), 2.73 (3H, s, 5’-Me), 7.42-7.44 (2H, m), 7.48 (1H, t, 
J = 7.2 Hz), 7.62 (1H, dd, J = 8.0, 8.8 Hz), 7.82 (1H, q, J = 1.2 Hz, 5-H), 7.89 (1H, d, J = 7.2 Hz), 8.02 
(1H, d, J = 8.8 Hz). 13C-NMR (100 MHz, (CD3)2CO) δ : 10.3, 19.7, 102.9, 119.4, 120.5, 123.2, 123.3, 
124.1, 124.3, 126.2, 127.2, 128.0, 134.8, 135.4, 147.5, 147.6, 161.7. IR (KBr) cm-1 : 781, 943, 1051, 1074, 
1140, 1219, 1281, 1404, 1495, 1599, 1726, 3121. Anal.calcd for C17H13IO3 : C, 52.06 ; H, 3.34. Found : C, 
51.81 ; H, 3.39. 
Neo-tanshinlactone (1)1  
A mixture of 14 (49.8 mg, 0.127 mmol), Pd(OAc)2 (3.5 mg, 0.016 mmol), nBu3P (4.9 mg, 0.024 mmol), 
Ag2CO3 (70.1 mg, 0.254 mmol), and DMA (3 mL) was heated for 10 min at 160 oC. The mixture was 
diluted with ethyl acetate and the undissolved materials were filtered off. Water was added to the mixture, 
and the organic layer was collected. The solution was washed with brine and dried over MgSO4, and then 
the solvent was evaporated. After purification by silica gel column chromatography (hexane: Et2O = 
10:1), pure 1 (19.1 mg, 57%) was obtained as a colorless solid, mp 228.6 - 229.0 ºC (hexane-AcOEt) 
[lit.,1 173-175 oC (hexane-AcOEt)]. 1H-NMR (400 MHz, CDCl3) δ : 2.41 (3H, d, J = 1.2 Hz), 2.74 (3H, s), 
7.45 (1H, q, J = 1.2 Hz), 7.46 (1H, d, J = 8.4 Hz), 7.55 (1H, t, J = 8.4 Hz), 7.88 (1H, d, J = 8.8 Hz), 7.92 
(1H, d, J = 8.8 Hz), 8.50 (1H, d, J = 8.4 Hz). 13C-NMR (100 MHz, CDCl3) δ : 8.7, 19.8, 108.2, 110.4, 
116.8, 120.5, 120.9, 121.0, 123.6, 127.0, 129.0, 133.4, 134.7, 141.2, 149.7, 158.8. IR (KBr) cm-1 : 771.5, 
1011, 1076, 1171, 1381, 1578, 1620, 1726, 2922, 2970. 
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